Resultados de la búsqueda 111-120 of 4445 for ❓팔로우주소 【위너보증.com / 가입코드 9122】 색계열가입코드 ❓

  1. Hematología - Ensayos clínicos - Mayo Clinic

    ... follow-up therapy. Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    ... follow-up therapy. Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of ...

  5. Neurología - Ensayos clínicos - Mayo Clinic

    ... follow-up therapy. Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    ... follow-up therapy. Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    ... follow-up therapy. Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of ...